Natriuretic Peptides
-
Subject Areas on Research
- A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.
- A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
- Beyond Natriuretic Peptides for Diagnosis and Management of Heart Failure.
- Biology of the natriuretic peptides.
- Biomarker guided therapy for heart failure: focus on natriuretic peptides.
- Biomarkers in Pulmonary Vascular Disease: Gauging Response to Therapy.
- Biomarkers in acute heart failure.
- Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.
- Biomarkers in stable coronary artery disease.
- Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.
- Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort.
- Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial.
- Does the relationship between natriuretic hormones and diastolic function differ by race?
- Emerging biomarkers in heart failure.
- Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials.
- GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
- Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
- Hemoconcentration-guided diuresis in heart failure.
- Influence of sex and hormone status on circulating natriuretic peptides.
- Multi-marker strategy of natriuretic peptide with either conventional or high-sensitivity troponin-T for acute coronary syndrome diagnosis in emergency department patients with chest pain: from the "Rule Out Myocardial Infarction using Computer Assisted Tomography" (ROMICAT) trial.
- Natriuretic Peptide-guided therapy for heart failure.
- Natriuretic Peptides in Older Patients With Heart Failure: A Look Into the Seeds of Time.
- Natriuretic peptide guided heart failure management.
- Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
- Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study.
- Natriuretic peptide testing in clinical medicine.
- Natriuretic peptides as biomarkers in heart failure.
- Natriuretic peptides for guiding heart failure therapy.
- Natriuretic peptides in heart failure and acute coronary syndrome.
- Natriuretic peptides in the diagnosis and management of acute heart failure.
- Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
- Patient selection in heart failure with preserved ejection fraction clinical trials.
- Post-acute care: the role of natriuretic peptides.
- Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
- Purification, cDNA sequence, and tissue distribution of rat uroguanylin.
- Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).
- Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals.
- ST2: a novel biomarker for heart failure.
- Sepsis and those who are "weak of heart".
- The evolution of the natriuretic peptides - Current applications in human and animal medicine.
- The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.
- The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
- The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.
- The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure.
- The role of natriuretic peptides: from the emergency department throughout hospitalization.
- Therapeutic implications of biomarkers in chronic heart failure.
- Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials.
- Will Biomarkers Succeed as a Surrogate Endpoint in Heart Failure Trials?
-
Keywords of People
- O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology